154 related articles for article (PubMed ID: 32449271)
21. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
22. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.
Grünblatt E; Mandel S; Maor G; Youdim MB
J Neurochem; 2001 Apr; 77(1):146-56. PubMed ID: 11279270
[TBL] [Abstract][Full Text] [Related]
23. Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?
Gupta SP; Patel S; Yadav S; Singh AK; Singh S; Singh MP
Neurochem Res; 2010 Aug; 35(8):1206-13. PubMed ID: 20455021
[TBL] [Abstract][Full Text] [Related]
24. β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease.
Ojha S; Javed H; Azimullah S; Haque ME
Mol Cell Biochem; 2016 Jul; 418(1-2):59-70. PubMed ID: 27316720
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
26. The neuroprotective effects of hydro-alcoholic extract of olive (Olea europaea L.) leaf on rotenone-induced Parkinson's disease in rat.
Sarbishegi M; Charkhat Gorgich EA; Khajavi O; Komeili G; Salimi S
Metab Brain Dis; 2018 Feb; 33(1):79-88. PubMed ID: 29039078
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
Pan X; Chen C; Huang J; Wei H; Fan Q
Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
[TBL] [Abstract][Full Text] [Related]
28. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S
Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effect of naringenin against MPTP-induced oxidative stress.
Sugumar M; Sevanan M; Sekar S
Int J Neurosci; 2019 Jun; 129(6):534-539. PubMed ID: 30433834
[TBL] [Abstract][Full Text] [Related]
30. Benefits of betanin in rotenone-induced Parkinson mice.
Thong-Asa W; Jedsadavitayakol S; Jutarattananon S
Metab Brain Dis; 2021 Dec; 36(8):2567-2577. PubMed ID: 34436745
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
Farombi EO; Awogbindin IO; Farombi TH; Oladele JO; Izomoh ER; Aladelokun OB; Ezekiel IO; Adebambo OI; Abah VO
Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
[TBL] [Abstract][Full Text] [Related]
32. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease.
Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N
J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427
[TBL] [Abstract][Full Text] [Related]
33. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T
J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.
Javed H; Azimullah S; Abul Khair SB; Ojha S; Haque ME
BMC Neurosci; 2016 Aug; 17(1):58. PubMed ID: 27549180
[TBL] [Abstract][Full Text] [Related]
35. Riluzole neuroprotection in a Parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation.
Carbone M; Duty S; Rattray M
BMC Neurosci; 2012 Apr; 13():38. PubMed ID: 22480308
[TBL] [Abstract][Full Text] [Related]
36. The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats.
Habib CN; Mohamed MR; Tadros MG; Tolba MF; Menze ET; Masoud SI
Eur J Pharmacol; 2022 Jan; 914():174573. PubMed ID: 34656609
[TBL] [Abstract][Full Text] [Related]
37. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
38. Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.
Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Oluwafemi OA; Onuelu JE; Adeyemi OO
Brain Res; 2022 Aug; 1789():147958. PubMed ID: 35654119
[TBL] [Abstract][Full Text] [Related]
39. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
[TBL] [Abstract][Full Text] [Related]
40. Cordycepin Exerts Neuroprotective Effects via an Anti-Apoptotic Mechanism based on the Mitochondrial Pathway in a Rotenone-Induced Parkinsonism Rat Model.
Jiang X; Tang P-C ; Chen Q; Zhang X; Fan Y-Y ; Yu BC; Gu X-X ; Sun Y; Ge X-Q ; Zhang X-L
CNS Neurol Disord Drug Targets; 2019; 18(8):609-620. PubMed ID: 31486758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
